Skip to content
OpenCapital
Get started

Evolent Health, Inc. EVH Q1 2026 earnings

Reported May 7, 2026 · Before market open

Revenue$496.2MMiss by $37.8M
EPS-$0.02Beat by $0.03
Revenue estimate$534.0M
EPS estimate-$0.05

Next report

Aug 6, 2026 (In 1 week)
Revenue estimate$597.7M
EPS estimate-$0.01

Financials

Q1 2026

Income statement

See full
Revenue$496.2M+2.6%
Gross profit$83.8M-18.2%
Operating income-$10.6M-553%
Net income-$26.6M+58.8%
EPS (diluted)-$0.24+61.9%

Balance sheet

See full
Cash & equivalents$142.0M-42.4%
Total debt$985.4M+13.3%
Total equity$396.4M-57.6%
Total assets$1.9B-29.2%

Cash flow

See full
Operating cash flow-$984.0K-122%

Valuation & ratios

Valuation

as of 07/29/26
See full
Market cap$420.68M-61.9%
Enterprise value$1.26B-30.0%
P/S0.2×-0.3×

Profitability

See full
Gross margin20.2%+4.9pp
Operating margin-22.2%-23.5pp
Net margin-26.3%-33.2pp

Returns & leverage

See full
Return on equity-74.6%-90.1pp
Debt / equity2.5×+1.6×
Current ratio1.3×+0.3×

Segments

By product

See full
Performance Suite$323.3M+31.9%
Specialty Technology and Services Suite$80.8M-2.4%
Administrative Services$49.6M-13.3%
Cases$42.6M+4.8%

By segment

See full
Evolent Health Services Segment$496.2M+2.6%

Versus estimates

Revenue

Q1 2026$496.2MMiss by $37.8M
Q4 2025$468.7MIn lineQ3 2025$479.5MBeat by $11.1MQ2 2025$444.3MMiss by $87.9MQ1 2025$483.6MBeat by $23.4MQ4 2024$646.5MMiss by $4.4M

Diluted EPS

Q1 2026-$0.02Beat by $0.03
Q4 2025$0.08Beat by $0.02Q3 2025$0.05Miss by $0.05Q2 2025-$0.10Miss by $0.19Q1 2025$0.06Miss by $0.03Q4 2024-$0.02Miss by $0.40

Ask the moment Evolent Health, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Evolent Health, Inc. report Q1 2026 earnings?
Evolent Health, Inc. (EVH) reported Q1 2026 earnings on May 7, 2026 before market open.
What were Evolent Health, Inc.'s Q1 2026 revenue and EPS?
Evolent Health, Inc. reported revenue of $496.2M and eps of $-0.02 for Q1 2026.
Did Evolent Health, Inc. beat estimates in Q1 2026?
Revenue missed the consensus estimate of $534.0M by $37.8M. EPS beat the consensus estimate of $-0.05 by $0.03.
How did Evolent Health, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 2.6% from $483.6M a year earlier.
Where can I find Evolent Health, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001628908-26-000031) and the 10-Q periodic report (0001628908-26-000033) directly on SEC EDGAR. The filing index links above go to sec.gov.